FOXO1 and neoplasm: Yet, the upstream cues (AMPK versus AKT versus eicosanoid signalling), the dominant FoxO isoform (FoxO1 versus FoxO3), and the pathological drivers (hyperglycemia, inflammation, tumor burden, hyperlipidemia) differ.